School protocol has been focused on exclusion from the get go.
Booster uptake has been quite good nationwide. Messaging on the boosters has been somewhat better. I’ve also seen a few spots on TV and even heard one on the radio. This is good, in my opinion.
Not liking what I’m seeing in the UK. Must be the new sub-variants. The best-case scenario would be that the uptick fizzles somehow as it comes up against a sizable immunity wall. Yet, that presumes the sub-variants don’t have a lot of escape immunity.
Parsing the data, we see that the usual suspects – includes Massachusetts – are at the top of the list for increases in cases. I say usual suspects, referring to those states that get hit first by the latest (sub)variants (which began hitting the UK and Europe 10-14 days ago). At this point it’s not rocket science. It’s a very well-established pattern. I’m really glad the booster uptake has been so good thus far.
14-day change:
NY +45%
MA + 40%
NJ + 32%
RI + 18%
DC + 21%
What I will be looking for in UK data is whether the case/hospitalization increase continues to grow steadily or even exponentially or whether it flattens fairly quickly. The latter would be a very hopeful sign. I’m all for hope at this point.
I wasn’t being facetious when I said “I’m really glad the booster uptake has been so good thus far.” One might interpret it as being facetious after I had noted the uptick in cases in the Northeast. But, with good booster uptake disease severity will be much lower, even among the vulnerable.
I am certainly going to get my booster as soon as the Brigham sets up their clinics. I already got my flu shot at the very beginning of this month.
C-19
9-24
ready
Comments are closed.
Your no-hype southeastern New England weather blog!
indeed
https://twitter.com/amytanmd/status/1572603551171612672?s=46&t=BVtXdIEYO_cPN0VXyIoNPA
School protocol has been focused on exclusion from the get go.
Booster uptake has been quite good nationwide. Messaging on the boosters has been somewhat better. I’ve also seen a few spots on TV and even heard one on the radio. This is good, in my opinion.
Not liking what I’m seeing in the UK. Must be the new sub-variants. The best-case scenario would be that the uptick fizzles somehow as it comes up against a sizable immunity wall. Yet, that presumes the sub-variants don’t have a lot of escape immunity.
Parsing the data, we see that the usual suspects – includes Massachusetts – are at the top of the list for increases in cases. I say usual suspects, referring to those states that get hit first by the latest (sub)variants (which began hitting the UK and Europe 10-14 days ago). At this point it’s not rocket science. It’s a very well-established pattern. I’m really glad the booster uptake has been so good thus far.
14-day change:
NY +45%
MA + 40%
NJ + 32%
RI + 18%
DC + 21%
What I will be looking for in UK data is whether the case/hospitalization increase continues to grow steadily or even exponentially or whether it flattens fairly quickly. The latter would be a very hopeful sign. I’m all for hope at this point.
I wasn’t being facetious when I said “I’m really glad the booster uptake has been so good thus far.” One might interpret it as being facetious after I had noted the uptick in cases in the Northeast. But, with good booster uptake disease severity will be much lower, even among the vulnerable.
I am certainly going to get my booster as soon as the Brigham sets up their clinics. I already got my flu shot at the very beginning of this month.
C-19
9-24
ready